Cerebrospinal Fluid and Plasma Viral Load in HIV-1-infected Patients with Various Anti-retroviral Treatment Regimens

By GisslÉn Magnus   Svennerholm Bo   Norkrans Gunnar   FranzÉn Christer   SÄll Christer   Svensson Rune   Öberg Sven   Hagberg Lars  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 4, 2000-10 ,pp. : 365-369

Informa Healthcare

Access to resources Recommend Favorite

Time to viral load suppression in antiretroviral‐naive and ‐experienced HIV‐infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 120, Iss. 12, 2013-11 ,pp. : 1534-1547

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persistently raised plasma levels of platelet‐derived inflammatory mediators in HIV‐infected patients during highly active anti‐retroviral therapy

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 1075-1077

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nephrotoxicity Associated with Antiretroviral Therapy in HIV-Infected Patients

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

Use of the Protease Inhibitor Saquinavir Hard Gel in Human Immunodeficiency Virus-infected Patients in the Early Period of Highly Active Antiretroviral Therapy: Does it Affect Long-term Treatment Outcome?

By Jensen-fangel Søren   Pedersen Court   Nielsen Henrik   Tauris Palle   Møller Axel   Sørensen Henrik Toft   Obel Niels  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 743-749

Informa Healthcare

Access to resources Recommend Favorite